Next Article in Journal
Characterization of the Weimberg Pathway in Caulobacter crescentus
Next Article in Special Issue
The Smell of Synthetic Biology: Engineering Strategies for Aroma Compound Production in Yeast
Previous Article in Journal
End-User Software for Efficient Sensor Placement in Jacketed Wine Tanks
Previous Article in Special Issue
Fluorinated Phenylalanine Precursor Resistance in Yeast
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview
Fermentation 2018, 4(2), 43;

Micro- and Nanoscale Approaches in Antifungal Drug Discovery

Alliance Research Group VUB-UGent NanoMicrobiology (NAMI), IJRG VUB-EPFL NanoBiotechnology & NanoMedicine (NANO), Research Group Structural Biology Brussels, Vrije Universiteit Brussel, 1050 Brussels, Belgium
Department Bioscience Engineering, University Antwerp, 2020 Antwerp, Belgium
Received: 7 May 2018 / Revised: 4 June 2018 / Accepted: 5 June 2018 / Published: 11 June 2018
(This article belongs to the Special Issue Yeast Biotechnology 2.0)
Full-Text   |   PDF [1371 KB, uploaded 11 June 2018]   |  


Clinical needs for novel antifungal agents have increased due to the increase of people with a compromised immune system, the appearance of resistant fungi, and infections by unusual yeasts. The search for new molecular targets for antifungals has generated considerable research, especially using modern omics methods (genomics, genome-wide collections of mutants, and proteomics) and bioinformatics approaches. Recently, micro- and nanoscale approaches have been introduced in antifungal drug discovery. Microfluidic platforms have been developed, since they have a number of advantages compared to traditional multiwell-plate screening, such as low reagent consumption, the manipulation of a large number of cells simultaneously and independently, and ease of integrating numerous analytical standard operations and large-scale integration. Automated high-throughput antifungal drug screening is achievable by massive parallel processing. Various microfluidic antimicrobial susceptibility testing (AST) methods have been developed, since they can provide the result in a short time-frame, which is necessary for personalized medicine in the clinic. New nanosensors, based on detecting the nanomotions of cells, have been developed to further decrease the time to test antifungal susceptibility to a few minutes. Finally, nanoparticles (especially, silver nanoparticles) that demonstrated antifungal activity are reviewed. View Full-Text
Keywords: antifungal drug discovery; microfluidics; nanobiotechnology; omics-based approaches; antifungal susceptibility testing; nanomotion detection; nanoparticles antifungal drug discovery; microfluidics; nanobiotechnology; omics-based approaches; antifungal susceptibility testing; nanomotion detection; nanoparticles

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Willaert, R.G. Micro- and Nanoscale Approaches in Antifungal Drug Discovery. Fermentation 2018, 4, 43.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Fermentation EISSN 2311-5637 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top